CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 104 enrolled
Drug / intervention
Non-Interventional Studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03040115
NCT03040115N/ACompleted

Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome

University of Cincinnati·observational·Posted Feb 2, 2017·Updated Jan 31, 2024

In Brief

An observational study evaluating Non-Interventional Study for Birt-Hogg-Dube Syndrome. Completed, enrolled 104 participants across 1 site.

Detailed Summary

The aim of this study is to conduct survey-based assessments for the safety of air travel in patients with Birt-Hogg-Dube syndrome (BHD). The study will enroll patients through the clinic network at Rare Lung Disease Consortium (RLDC) and through the BHD foundation website. Patients will have access to the questionnaire via REDCap (an online data management system) and each patient will be provided with a link to complete the survey. The investigators plan on enrolling approximately 100 patients with BHD for the purpose of this study. Secondary aims of this study include further characterization of the clinical aspects of disease and to establish a contact registry for these patients, in order to facilitate future studies.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 2, 2017
Enrollment StartAug 1, 2015
Primary CompletionAug 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 9.4 years ago

Interventions

Non-Interventional Studyother